Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 27, 2015 4:34 PM ET

Healthcare Providers and Services

Company Overview of Musculoskeletal Transplant Foundation

Company Overview

Musculoskeletal Transplant Foundation, a non-profit tissue bank, provides grafts for transplantations. It offers bone and soft tissue grafts in the United States. Musculoskeletal Transplant Foundation was founded in 1987 and is based in Edison, New Jersey. The company has facilities in Pennsylvania, California, Minnesota, and Germany, as well as recovery sites in Wisconsin, California, Illinois, and New York. As of May 17, 2010, Musculoskeletal Transplant operates as a subsidiary of California Transplant Donor Network.

125 May Street

Edison, NJ 08837

United States

Founded in 1987





Key Executives for Musculoskeletal Transplant Foundation

Chief Executive Officer and President
Age: 65
Chief Financial Officer, Executive Vice President of Operations and President of Skin/CV Division
Executive Vice President of Processing Operations
Executive Vice President of Research & Development
Executive Vice President of Donor Services
Compensation as of Fiscal Year 2015.

Musculoskeletal Transplant Foundation Key Developments

The Musculoskeletal Transplant Foundation Reconfirms Favorable Ruling from the Patent Trial and Appeal Board

The Musculoskeletal Transplant Foundation (MTF) reconfirmed on September 1, 2015 that the Patent Trial and Appeal Board of the United States Patent and Trademark Office has ruled in favor of MTF's inter partes review challenge to the EpiFix patent (U.S. Patent No. 8,372,437) asserted in the related lawsuit brought by MiMedx Group, Inc. against MTF, Liventa Bioscience, Inc., and Medline Industries, Inc. The '437 Patent is the initial patent in a family that includes two other EpiFix patents involved in the MiMedx lawsuit (US Patent Nos. 8,597,687 and 8,709,494).

MiMedx Group Announces Update on Outstanding Patent Litigation Filed in the Spring

MiMedx Group announced an update on outstanding patent litigation filed in the spring. The company uses human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare. MiMedx has repeatedly stated that it will vigorously defend and enforce its patent portfolio against infringement by third parties.To that end, MiMedx filed two separate patent infringement lawsuits, including an action pending in the Northern District of Georgia against Musculoskeletal Transplant Foundation, Liventa and Medline and another action pending in the Western District of Texas against Bone Bank, et al. Both lawsuits are in the "discovery phase" and "claim construction phase." During the discovery phase, the parties gather from each other and third parties information about the facts and issues in the case. While in the claim construction phase, the Court will engage in a determination of the meaning of the metes and bounds of certain claim terms in dispute between the parties. As expected, the defendants are alleging that their respective products do not infringe MiMedx's patents and/or that the company's patents are invalid, the company said in a release. A defendant seeking to invalidate a patent claim as a defense to a lawsuit must prove invalidity by "clear and convincing evidence." This is a higher evidentiary standard than what a plaintiff, such as MiMedx, has to meet in order to prove infringement, it said. To avoid this higher standard, many defendants are attempting to challenge the validity of a plaintiff's patent claims outside of court through a more recent process known as "inter partes review".

MiMedx Group Files Lawsuit Against Liventa, Medline, And Musculoskeletal Transplant Foundation

MiMedx Group, Inc. announced that it has filed a patent infringement lawsuit against Liventa Bioscience, Inc., Medline Industries, Inc. and Musculoskeletal Transplant Foundation, Inc. for permanent injunctive relief and unspecified damages. In addition to the allegations of infringement of MiMedx's patents, the lawsuit asserts that Liventa and Medline knowingly and willfully made false and misleading representations about their respective products to providers, patients and in some cases, prospective investors. The suit was filed in the United States District Court for the Northern District of Georgia. In the suit, MiMedx asserts that Liventa, Medline and MTF infringed and continue to infringe at least four MiMedx patents: US 8,323,701 -- Placental Tissue Grafts, US 8,642,092 -- Placental Tissue Grafts, US 8,372,437 - Placental Tissue Grafts and US 8,597,687 -- Methods for Determining the Orientation of a Placental Tissue Graft. The patents at issue relate to the MiMedx dehydrated human amnion/chorion membrane allografts. MTF is the processor and Liventa and Medline are the distributors of the allegedly infringing products.

Similar Private Companies By Industry

Company Name Region
Oklahoma Spine Hospital, L.L.C. United States
Seminole Medical Center United States
Skilled Care Pharmacy, Inc. United States
Care IV Inc. United States
Culpeper Memorial Hospital, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Musculoskeletal Transplant Foundation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at